comparemela.com

Latest Breaking News On - Kura oncology company profile - Page 6 : comparemela.com

Kura Oncology, Inc (NASDAQ:KURA) Given Average Recommendation of Moderate Buy by Analysts

Kura Oncology, Inc (NASDAQ:KURA) Given Average Recommendation of Moderate Buy by Analysts
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Cantor Fitzgerald Reaffirms Overweight Rating for Kura Oncology (NASDAQ:KURA)

Kura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a research report issued to clients and investors on Friday, Benzinga reports. They currently have a $30.00 target price on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 172.73% from the […]

Short Interest in Kura Oncology, Inc (NASDAQ:KURA) Expands By 21 2%

Kura Oncology, Inc. (NASDAQ:KURA – Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 7,440,000 shares, a growth of 21.2% from the May 31st total of 6,140,000 shares. Based on an average daily volume of 827,500 shares, the short-interest ratio is […]

Kura Oncology (NASDAQ:KURA) Stock Price Down 3 6%

Kura Oncology, Inc. (NASDAQ:KURA – Get Rating)’s stock price traded down 3.6% on Thursday . The company traded as low as $11.04 and last traded at $11.06. 912,644 shares changed hands during mid-day trading, an increase of 32% from the average session volume of 692,360 shares. The stock had previously closed at $11.47. Analyst Ratings […]

Kura Oncology, Inc (NASDAQ:KURA) Given Average Recommendation of Moderate Buy by Brokerages

Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the eight analysts that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and six have given a buy recommendation to the company. The average twelve-month price […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.